Skip to main content
. Author manuscript; available in PMC: 2011 Feb 1.
Published in final edited form as: Cancer Res. 2010 Jan 26;70(3):875–882. doi: 10.1158/0008-5472.CAN-09-2762

Table 2.

Most frequent adverse events possibly, probably, or definitely related to treatment for all treatment cycles and dose levels

Toxicity Grade
1
2
n (%) n (%)
Pain—abdominal 4 (19.0) 4 (19.0)
Fatigue 7 (33.3) 2 (9.5)
Fever—no neutropenia 8 (38.1) 0 (0)
Abdominal distention 5 (23.8) 0 (0)
Anorexia 6 (28.6) 1 (4.8)
Nausea 4 (19.0) 2 (9.5)